KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

Petmed Express (PETS) Total Non-Current Liabilities (2022 - 2023)

Petmed Express has reported Total Non-Current Liabilities over the past 2 years, most recently at $58.5 million for Q3 2023.

For Q3 2023, Total Non-Current Liabilities changed N/A year-over-year to $58.5 million; the TTM value through Sep 2023 reached $58.5 million, changed N/A, while the annual FY2023 figure was $53.7 million, 4.55% down from the prior year.
Total Non-Current Liabilities for Q3 2023 was $58.5 million at Petmed Express, down from $76.2 million in the prior quarter.
Over five years, Total Non-Current Liabilities peaked at $76.2 million in Q2 2023 and troughed at $53.7 million in Q1 2023.